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Renovascular disease in older patients beginning renal replacement
therapy. Renovascular disease (RVD) in older patients can cause pro-
gressive renal insufficiency and even end-stage renal disease (ESRD). The
frequency of this clinical problem is not well defined. Renal duplex
sonography (RDS) correctly identifies the presence of RVD with an
overall accuracy of approximately 95%. Therefore, the purpose of this
study was to utilize RDS as a noninvasive tool to identify the presence of
critical RVD (60% diameter-reducing stenosis or occlusion) in patients
50 years of age or older beginning renal replacement therapy. A total of 53
consecutive participating patients were prospectively interrogated. Com-
plete interrogations occurred in 45 of the 53 patients (85%), and 92 of the
103 kidneys (89%). Critical RVD was noted in 10 of 45 patients (22%).
RVD was bilateral in 5 patients, unilateral in 5 patients, and there were 4
renal artery occlusions noted. All patients with critical RVD were white
(10 of 25 white patients or 40%). Total pack years of smoking as well as
associated cardiovascular and cerebrovascular conditions were greater in
those patients with critical RVD compared to those without. These results
indicate that RDS remains technically feasible as renal blood flow and
function decline. Unsuspected RVD possibly contributory to renal insuf-
ficiency exists in a significant number of primarily white patients 50 years
of age or older beginning renal replacement therapy. These patients are
generally smokers with a high frequency of associated extrarenal athero-
sclerosis. The addition of RVD as a separate category of disease causing
ESRD would improve U.S. Renal Data System ESRD classification. RVD
should be recognized as a cause of ESRD.
In recent years, the importance of renovascular disease (RVD)
as a cause of progressive renal insufficiency has been emphasized
[1, 2]. The frequency of this clinical problem is not well defined,
although unsuspected RVD causing renal insufficiency may exist
in a significant number of older patients felt clinically to have
hypertensive nephropathy [1]. Both autopsy and angiographic
studies suggest that RVD is not uncommon with increasing age,
especially in patients with evidence of extrarenal atherosclerosis
[3]. Additionally, a number of studies suggest that renal artery
atherosclerosis may progress and be associated with deterioration
in renal function [4, 5]. Furthermore, recent work suggests that
approximately 15% of patients 50 years of age or older with
end-stage renal disease (ESRD) may have critical RVD as the
primary cause [6, 7]. Invasive procedures such as renal artery
repair may improve renal function, delay progression of disease
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and even remove patients from dialysis therapy [8, 9]. Therefore,
it is important to identify critical RVD since it may be potentially
treatable.
We have found that renal duplex sonography (RDS) correctly
identifies the presence of RVD with an overall accuracy of
approximately 95% [10]. In our institution, RDS is an ideal
screening test for RVD. Exam time is brief, minimal prep is
required, and there is no threat to remaining renal function. RDS
combines direct visualization of renal architecture with doppler
measurement of renal artery blood flow velocity resulting in both
anatomic and functional assessment, and it is not affected ad-
versely by bilateral renal artery disease or renal insufficiency.
Therefore, the purpose of this study was to utilize RDS as a
noninvasive tool to identify the presence of critical RVD, that is 
60% diameter-reducing stenosis or occlusion, in patients 50 years
of age or older beginning renal replacement therapy. As will be
discussed, the finding of critical RVD does not necessarily imply
cause and effect.
Methods
Subjects
Subjects were obtained from patients presenting to the dialysis
centers of the Bowman Gray School of Medicine for institution of
renal replacement therapy. Ninety consecutive patients 50 years of
age or older were prospectively entered into the study over a
period of approximately seven months. All patients in the area
presenting for renal replacement therapy were captured, as all
community and university-affiliated nephrologists allowed their
patients to be studied. The protocol was approved by the Clinical
Research Practices Committee of the Bowman Gray School of
Medicine.
Renal duplex sonography
Subjects were fasted overnight. Renal duplex sonography
(RDS) was performed with an Ultramark-9 HDI Ultrasound
System (Advanced Technologies Laboratories, Bothell, Washing-
ton, USA). This is a fully digitized ultrasound system combining
high definition B-scan images with fast-Fourier transform spectral
analysis of the Doppler-shifted renal artery signal. A 3.0 mHz
mechanical long-focus probe and a 2.25 mHz phased-array probe
with color flow imaging were utilized. The technique has been
previously described [10]. Briefly, with the patient supine, a
B-scan image of the aorta and proximal superior mesenteric artery
and left renal vein was obtained. Using the renal vein as a visual
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Table 1. Clinical characteristics of participants versus nonparticipants
Characteristic
Participants(N = 53)
Nonparticipants(N = 37) p
Age years 65.0 1.1 70.3 1.7 0.007
Black/white 21/32 16/21 NS
Female/male 27/26 15/22 NS
Diagnosis NS
DM 26 14
HTN 6 7
RVD 2 1
CGN 6 5
AE 2 2
CIN 5 4
UNK 6 4
Abbreviations are: NS, not significant; DM, diabetic nephropathy;
HTN, hypertension nephropathy; RVD, renovascular disease; CGN,
chronic glomerulonephritis; AE, atheroembolic disease; CIN, chronic
interstitial nephritis; UNK, unknown.
reference, the aortic origins of both main renal arteries were
identified. Doppler samples were taken from each renal artery
from aorta to renal hilum and renal artery peak systolic velocity
was calculated. Peak systolic velocities were confirmed using a
flank approach and a B-scan image of each kidney was obtained in
order to determine kidney length, width and thickness. A study
was determined to be negative for critical RVD (< 60% diameter-
reducing renal artery stenosis) when renal artery peak systolic
velocity from aortic origin to renal hilum was less than 2.0
meters/second. A study was determined to be positive for critical
RVD (60% diameter-reducing stenosis or occlusion) when a
focal renal artery peak systolic velocity  2.0 meters/second and a
distal turbulent Doppler waveform was noted. An artery was
noted to be occluded when there was an absence of Doppler
shifted signal from an imaged vessel. A RDS exam was noted to be
incomplete when renal artery Doppler samples were not obtained
from aortic origin to renal hilum.
Data analysis
Demographic data including age, sex, race, and presumed
diagnosis causing ESRD were obtained from chart reviews and
compared in subjects who were participants versus nonpartici-
pants; in participating subjects with complete versus incomplete
RDS exams; and in participating subjects with complete exams
who had critical RVD versus no critical RVD. A number of
parameters such as hypertension, smoking, associated cardiovas-
cular, cerebrovascular, and peripheral vascular conditions, choles-
terol, renal size, and renal functional decline were compared in
subjects with critical RVD versus subjects without critical RVD.
Where appropriate, results are expressed as means SEM.
Comparison of group mean values was performed using the
Student's t-test. In comparing subgroups, analysis was per-
formed utilizing Mantel-Haenszel and data were considered
statistically significant if P < 0.05.
Results
Of the 90 consecutive patients 50 years of age or older who were
prospectively entered into the study, 37 refused RDS examina-
tion. Many of these patients were old and debilitated and resided
in nursing homes, making it difficult for them to come to the
Table 2. Clinical characteristics of participants with complete RDS
exam versus incomplete RDS exam
Characteristic Complete Incomplete P
No. of patients 45 (85%) 8 (15%)
No. of kidneys 92 (89%) 11(11%)
Age years 65.3 1.2 63.9 1.9 NS
Black/white 20/25 1/7 0.09
Female/male 25/20 2/6 NS
Diagnosis NS
DM 22 4
HTN 5 1
RVD 2 0
CGN 6 0
AE 2 0
CIN 3 2
UNK 5 1
Abbreviations as described in Table 1.
Medical Center for RDS examination. Table 1 indicates that there
were no differences in race, gender or ESRD diagnoses in the
participating versus the nonparticipating subjects. The nonpartic-
ipants were older. Therefore, the two groups were comparable
and the older age of the nonparticipants would, as will be
discussed, only increase the likelihood that critical RVD was
present.
Table 2 shows demographic data from those patients with a
complete RDS exam versus those patients with an incomplete
exam. A total of 53 consecutive participating patients were
interrogated. Complete interrogations occurred in 45 of the 53
patients (85%). A total of 103 kidneys were interrogated with a
complete study occurring in 92 of the 103 kidneys (89%). These
exams are the most difficult that we perform because of the low
blood flow and small vessels and kidneys in these patients.
However, the results compare rather favorably to our experience
in patients without profound renal failure in whom the success
rate is closer to 95%. No attempt was made to repeat an
incomplete exam after improved bowel prep which would have
likely improved the success rate since excess bowel gas impaired a
number of these RDS exams. There was no difference in age,
gender, race, or ESRD diagnoses in the two groups (Table 2).
Data from the 45 participating patients with complete RDS
exams are now presented (Table 3). Critical RVD was noted in 10
of 45 patients (22%). If only white patients were included, 10 of 25
(40%) had critical RVD. RVD was bilateral in five patients,
unilateral in five patients, and there were four renal artery
occlusions noted. There was a tendency for the patients with RVD
to be older, and the minimum age of these patients at the onset of
dialysis was older. The most striking finding, however, was that all
10 patients with critical RVD were white. Taken as a whole, the
ESRD diagnoses in the two groups were not different.
We compared the history of smoking and hypertension in the
two groups (Table 4). Those patients with critical RVD had a
tendency toward more years of smoking than those patients
without. Total pack years of smoking was greater in those patients
with critical RVD. Nine of the 10 patients with critical RVD
(90%) were smokers. Both groups, as one would expect, had a
very significant history of hypertension. There was no difference in
serum cholesterol in the two groups (Table 4).
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Table 3. Clinical characteristics of participants with complete RDS
exams, RVD versus No RVD
Characteristic RVD No RVD P
No. of patients 10 (22%) 35 (78%)
White patients only 10 (40%) 15 (60%)
Bilateral/unilateral/occlusion 5/5/4
Mean age years 69.4 2.5 64.1 1.3 0.07
Minimum age years 56.3 50.1
Female/male 5/5 20/15 NS
Black/white 0/10 20/15 0.002
Diagnosis NS
DM 2 20
HTN 0 5 (all black)
RVD 2 0
CGN 3 3
AE 1 1
CIN 1 2
UNK 1 4
Abbreviations as described in Table 1.
Table 4. Smoking, hypertension, and cholesterol, RVD versus No RVD
Characteristic RVD No RVD P
Smoking years 27.7 4.1 16.4 3.0 0.07
Smoking pack years 37.4 7.4 17.1 3.8 0.016
Smoking 9 of 10 (90%) 18 of 34 (53%) 0.036
Hypertension years 14.7 3.3 12.3 1.9 NS
Hypertension 10 of 10 (100%) 30 of 32 (94%) NS
Cholesterol mg/dl 228.0 28.8 228.7 10.8 NS
NS, not significant.
Table 5. Associated cardiovascular conditions, RVD versus No RVD
Table 6. Associated cerebrovascular conditions, RVD versus No RVD
Condition RVD No RVD P
CVA 3 of 10 (30%) 1 of 35 (3%) 0.009
TIA 2 of 10 (20%) 1 of 35 (3%) 0.058
CEA 1 of 10 (10%) 1 of 35 (3%) NS
Total 4 of 10 (40%) 2 of 35 (6%) 0.005
Abbreviations are: CVA, cerebrovascular accident; TIA, transient isch-
emic attack; CEA, carotid endarterectomy; NS, not significant.
Table 7. Associated peripheral vascular conditions, RVD versus No
RVD
Condition RVD No RVD P
PVD 3 of 10 (30%) 4 of 35 (11%) NS
AAA 0 of 10 (0%) 2 of 35 (6%) NS
Amputation 0 of 10 (0%) 3 of 35 (9%) NS
Total 3 of 10 (30%) 7 of 35 (20%) NS
Abbreviations are: PVD, peripheral vascular disease; AAA, abdominal
aortic aneurysm; NS, not significant.
Table 8. Kidney size, RVD versus No RVD
Kidney size cm RVD No RVD P
Right 9.5 0.6 10.3 0.2 NS
Left 10.3 0.6 10.3 0.2 NS
0.9 0.7 0.0 0.2 0.19
Minimum 6.7 7.2
NS, not significant; difference between left and right.
Condition RVD No RVD P
Angina 5 of 10 (50%) 8 of 34 (24%)
MI 3 of 10 (30%) 7 of 34 (21%)
CABG 4of 10 (40%) 4of 35 (11%)
Total 7 of 10 (70%) 13 of 35 (37%)
0.111
NS
0.039
0.068
Abbreviations are: MI, myocardial infarction; CABG, coronary artery
bypass grafting; NS, not significant.
Associated cardiovascular conditions in the two groups were
compared (Table 5). The percentages of patients with angina,
myocardial infarction, and coronary artery bypass grafting were
higher in those patients with critical RVD compared with those
without. Likewise, associated cerebrovascular conditions such as
cerebrovascular accident, transient ischemic attack, and carotid
endarterectomy occurred more frequently in the group with
critical RVD (Table 6). There was no difference in associated
peripheral vascular conditions such as peripheral vascular disease,
abdominal aortic aneurysm, or amputation in the two groups
(Table 7). Many of the patients without critical RVD had diabetic
nephropathy and were prone to other complications of diabetes
including amputation.
There was no difference in the rate of renal functional decline
over the six months prior to RDS exam, in the groups with and
without critical RVD. Kidney size was compared in the two
groups (Table 8). No statistically significant differences were
noted, although there was a tendency for the difference between
right and left kidney size to be greater in the group with critical
RVD.
Discussion
A number of noninvasive screening tests are currently available
for diagnosing RVD [11, 12]. We and others have promoted the
use of RDS as an ideal screening tool [10—17]. The technique
distinguishes between <60% and  60% renal artery diameter-
reducing stenosis (including occlusion); experimental studies had
demonstrated that a 60% diameter-reducing stenosis was required
before a decrease in distal renal artery perfusion pressure and
blood flow was reproducibly noted [14]. RDS provides both
anatomic and functional information regarding renal artery dis-
ease, although when used as a percutaneous test RDS does not
provide detailed anatomic assessment of renal artery plaque. The
sensitivity and specificity of RDS is not adversely affected by
bilateral disease, nor by renal insufficiency which increases its
utility compared to other screening procedures particularly for the
diagnosis of ischemic nephropathy. This explains the rationale for
the use of RDS in the present study.
RDS has not been successfully utilized as an accurate screening
modality at a number of medical centers. The technique is
demanding, and therefore the results are operator-dependent.
Success requires a significant commitment in terms of time and
effort. At our center, the technique has been validated in two
prospective clinical studies comparing RDS with conventional
angiography [10, 13]. Combining the results from both studies, 156
patients had renal angiograms available for comparison with
RDS. The technique proved to be 94% sensitive, and 98% specific
in these 156 patients. In these studies, the overall accuracy of RDS
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Fig. 1. United States Renal Data System data
from 1994 showing causes of ESRD incidence in
the year 1991 [modified from 30] (A). Estimates
of yearly incidence of critical RVD causing
ESRD in all patients, patients  50years, and
white patients  50 years (B). These are only
estimates, based on data from the present work
and [6, 7]. Details are in the text.
was not affected in the subgroup of patients with declining renal
function and/or bilateral disease. Therefore, the test is quite
reliable at our center.
Excess bowel gas, obesity, and accessory renal arteries can
cause technical difficulties with RDS. Excess bowel gas occurred
in four of the eight incomplete patient studies. None of these
studies were repeated after a bowel prep, under which circum-
stances a complete study would likely have been possible. This
would have improved the success rate to 92%, closer to the 95%
experience in patients without profound renal insufficiency. Also,
as noted earlier, there were more nonparticipating patients than
one would have preferred. However, this was not unexpected,
given the poor general health status and nursing home residence
of many of these patients. Nonetheless, it should be stressed that
the nonparticipants were quite comparable to the participants in
terms of race, gender, and diagnosis (Table 1). They were older,
and our results indicate that this could only have increased the
likelihood of RVD.
This study highlights the common finding of extrarenal athero-
sclerosis in patients with critical RVD. Based on both autopsy [181
and arteriographic studies [19], it has been known for some time
that renal artery disease occurs not infrequently in older individ-
uals. More recently, the rather high prevalence of RVD in
patients with extrarenal atherosclerosis involving coronary dis-
ease, peripheral vascular disease, and carotid disease has been
noted [20—23]. Furthermore, other investigators have shown that
RVD may be progressive and may contribute to renal insufficiency
and ESRD [4—7, 24—261.
Our prospective work confirms and extends the data of Mail-
loux et al [6] and Scoble et al [7]. These studies utilized angiog-
raphy and/or other clinical parameters in order to document RVD
as a cause of ESRD in 16.5% [6] and 14% [7] of patients 50 years
of age or older entering ESRD programs. We cannot definitively
state that all of our patients with critical RVD had ischemic
nephropathy as a cause of ESRD. The relationship between RVD
and renal insufficiency is not always clear, and therefore the
finding of critical RVD does not necessarily imply cause and
effect. RDS is a functional tool, and a test positive for critical
RVD implies functional impairment of blood flow leading to
marked changes in peak systolic velocity as well as distal turbulent
Doppler waveforms. While blood flow is impaired, this does not
imply causality in terms of ESRD. Some authors believe that the
only way to do this is to show improvement after intervention. In
this regard, we recently reported our experience in the surgical
management of dialysis-dependent ischemic nephropathy [9].
Twenty consecutive patients on dialysis with critical RVD under-
went revascularization procedures. At one year post-operative, 14
of 20 (70%) were off dialysis. Overall, retrieval of renal function
was observed in 80% of patients with bilateral disease or disease
to a solitary kidney, and 33% of patients with unilateral disease.
Thus, these findings do suggest that a causal relationship may
exist, especially in patients with bilateral disease.
Presumed ESRD diagnoses in our patients with critical RVD
covered a spectrum (Table 3). If we include only patients with
bilateral disease, then 5 of 45 or 11% may have had ischemic
nephropathy. This number, which is very close to that found in the
two previously discussed reports [6, 7], is further supported by the
following. Three of the five patients actually had renal arterio-
graphic evidence of critical bilateral renal artery stenosis with
small kidneys or a discrepancy in kidney size. The fourth patient
was a white female smoker with a history of severe hypertension
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and small asymmetric kidneys. The fifth patient had evidence of
asymmetric kidneys and a renal artery occlusion.
The importance of diagnosing RVD should be underscored for
two reasons. These patients do quite poorly on dialysis [61.
Five-year survival is probably only 10% [61. Secondly, RVD is
potentially treatable as we and others have discussed [8, 9, 13,
27—29]. Mortality was statistically significantly reduced in those
patients removed from dialysis by operative intervention in our
recent report [9].
Figure 1A shows the most recent United States Renal Data
System (USRDS) data from 1994 showing ESRD incidence in the
year 1991 [30]. This classification indicates the percentage of
patients with ESRD due to diabetes mellitus, hypertension,
glomerulonephritis, cystic diseases, urologic diseases, other
known causes, unknown causes, and missing data. It is interesting
to note that RVD is not listed in this classification schema. If we
multiply the total number of cases (49,909) by 65% (estimate of
patients  50 years), and then multiply again by 11% (estimate of
patients with ischemic nephropathy as previously described), we
see that 3568 cases of ischemic nephropathy per year may not be
correctly classified. Ischemic nephropathy may therefore be the
fourth most common cause of ESRD in all patients, accounting
for 7% of total cases. Interestingly, in the study by Scoble et al [7],
ischemic nephropathy was felt to account for 6% of total cases,
remarkably similar results. In patients 50 years of age or older, the
estimate as noted previously would be 11% of cases; in white
patients 50 years of age or older, the estimate would be 20% of
cases based on those 5 of 25 in our study with bilateral disease
(Fig. 1B). As noted by Mailloux et al [31], the same classification
code is used for arteriolar nephrosclerosis, atheroembolic kidney
disease, hypertensive nephropathy, hypertensive renal disease,
nephrosclerosis, and renal vascular disease. This clearly results in
unnecessay misclassification. We also agree that the category of
hypertension (Fig. 1A) is likely overutilized. In our institution,
elderly white patients with ESRD are rarely diagnosed with
hypertensive ESRD (note zero white cases in Table 3). It is likely
that many of these patients are misclassified, and instead have
critical RVD or missed primary renal disease [32].
In summary, this study indicates that RDS remains technically
feasible as renal blood flow and function decline. In addition,
unsuspected RVD possibly contributory to renal insufficiency
exists in a significant number of primarily white patients 50 years
of age or older beginning renal replacement therapy. These
patients are generally smokers with a high frequency of associated
extrarenal atherosclerosis. Finally, USRDS should consider add-
ing RVD as a separate category of disease causing ESRD. This
would improve ESRD classification and recognition of ischemic
nephropathy, a potentially treatable disease.
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